Search research articles
Contact Us
Filters
Showing results (421-430 of 589) with videos related to
Page
of 59
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 3, 2016
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial
H W Rodbard, B W Bode, S B Harris, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Insights into MMP-TIMP interactions
W Bode, C Fernandez-Catalan, F Grams, et al.
Chemistry & Biology
|
April 28, 2001
Bivalent inhibition of human beta-tryptase
N Schaschke, G Matschiner, F Zettl, et al.
Protein Science : a Publication of the Protein Society
|
May 1, 1995
The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases
W Stöcker, F Grams, U Baumann, et al.
Science (New York, N.Y.)
|
July 20, 1990
The structure of a complex of recombinant hirudin and human alpha-thrombin
T J Rydel, K G Ravichandran, A Tulinsky, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2010
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes
B W Bode, M A Testa, M Magwire, et al.
Protein Science : a Publication of the Protein Society
|
July 9, 1998
Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data
H Brandstetter, R A Engh, E G Von Roedern, et al.
The Journal of Biological Chemistry
|
November 22, 1996
X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition
H Brandstetter, A Kühne, W Bode, et al.
Journal of Diabetes Science and Technology
|
September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections
Juan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Journal of Molecular Biology
|
February 5, 1999
The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity
P J Pereira, Z M Wang, H Rubin, et al.
Page
of 59
Search research articles
Search
Showing results (421-430 of 589) with videos related to
Sort By:
Page
of 59
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 3, 2016
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial
H W Rodbard, B W Bode, S B Harris, et al.
Annals of the New York Academy of Sciences
|
July 23, 1999
Insights into MMP-TIMP interactions
W Bode, C Fernandez-Catalan, F Grams, et al.
Chemistry & Biology
|
April 28, 2001
Bivalent inhibition of human beta-tryptase
N Schaschke, G Matschiner, F Zettl, et al.
Protein Science : a Publication of the Protein Society
|
May 1, 1995
The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases
W Stöcker, F Grams, U Baumann, et al.
Science (New York, N.Y.)
|
July 20, 1990
The structure of a complex of recombinant hirudin and human alpha-thrombin
T J Rydel, K G Ravichandran, A Tulinsky, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2010
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes
B W Bode, M A Testa, M Magwire, et al.
Protein Science : a Publication of the Protein Society
|
July 9, 1998
Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data
H Brandstetter, R A Engh, E G Von Roedern, et al.
The Journal of Biological Chemistry
|
November 22, 1996
X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition
H Brandstetter, A Kühne, W Bode, et al.
Journal of Diabetes Science and Technology
|
September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections
Juan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Journal of Molecular Biology
|
February 5, 1999
The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity
P J Pereira, Z M Wang, H Rubin, et al.
Page
of 59